Breast-lesion assessment using amide proton transfer-weighted imaging and dynamic contrast-enhanced MR imaging

1. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin 2022; 72: 7–33. doi: 10.3322/caac.21708 SiegelRL MillerKD FuchsHE JemalA Cancer statistics, 2022 CA Cancer J Clin 2022 72 7 33 10.3322/caac.21708 Open DOISearch in Google Scholar

2. Bakker MF, de Lange SV, Pijnappel RM, Mann RM, Peeters PHM, Monninkhof EM, et al. Supplemental MRI screening for women with extremely dense breast tissue. N Engl J Med 2019; 381: 2091–102. doi: 10.1056/NEJMoa1903986 BakkerMF de LangeSV PijnappelRM MannRM PeetersPHM MonninkhofEM Supplemental MRI screening for women with extremely dense breast tissue N Engl J Med 2019 381 2091 102 10.1056/NEJMoa1903986 Open DOISearch in Google Scholar

3. Sumkin JH, Berg WA, Carter GJ, Bandos AI, Chough DM, Ganott MA, et al. Diagnostic performance of MRI, molecular breast imaging, and contrast-enhanced mammography in women with newly diagnosed breast cancer. Radiology 2019; 293: 531–40. doi: 10.1148/radiol.2019190887 SumkinJH BergWA CarterGJ BandosAI ChoughDM GanottMA Diagnostic performance of MRI, molecular breast imaging, and contrast-enhanced mammography in women with newly diagnosed breast cancer Radiology 2019 293 531 40 10.1148/radiol.2019190887 Open DOISearch in Google Scholar

4. Jahani N, Cohen E, Hsieh MK, Weinstein SP, Pantalone L, Hylton N, et al. Prediction of treatment response to neoadjuvant chemotherapy for breast cancer via early changes in tumor heterogeneity captured by DCE-MRI registration. Sci Rep 2019; 9: 12114. doi: 10.1038/s41598-019-48465-x JahaniN CohenE HsiehMK WeinsteinSP PantaloneL HyltonN Prediction of treatment response to neoadjuvant chemotherapy for breast cancer via early changes in tumor heterogeneity captured by DCE-MRI registration Sci Rep 2019 9 12114 10.1038/s41598-019-48465-x Open DOISearch in Google Scholar

5. Zanello PA, Robim AF, Oliveira TM, Elias Junior J, Andrade JM, Monteiro CR, et al. Breast ultrasound diagnostic performance and outcomes for mass lesions using Breast Imaging Reporting and Data System category 0 mammogram. Clinics 2011; 66: 443–8. doi: 10.1590/s1807-59322011000300014 ZanelloPA RobimAF OliveiraTM Elias JuniorJ AndradeJM MonteiroCR Breast ultrasound diagnostic performance and outcomes for mass lesions using Breast Imaging Reporting and Data System category 0 mammogram Clinics 2011 66 443 8 10.1590/s1807-59322011000300014 Open DOISearch in Google Scholar

6. McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, et al. Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology 2015; 275: 772–82. doi: 10.1148/radiol.15150025 McDonaldRJ McDonaldJS KallmesDF JentoftME MurrayDL ThielenKR Intracranial gadolinium deposition after contrast-enhanced MR imaging Radiology 2015 275 772 82 10.1148/radiol.15150025 Open DOISearch in Google Scholar

7. Kim HJJon. Variability in quantitative DCE-MRI: sources and solutions. J Nat Sci 2018; 4: e484. KimH JJon. Variability in quantitative DCE-MRI: sources and solutions J Nat Sci 2018 4 e484 Search in Google Scholar

8. Alkhunizi SM, Fakhoury M, Abou-Kheir W, Lawand N. Gadolinium retention in the central and peripheral nervous system: implications for pain, cognition, and neurogenesis. Radiology 2020; 297: 407–16. doi: 10.1148/radiol.2020192645 AlkhuniziSM FakhouryM Abou-KheirW LawandN Gadolinium retention in the central and peripheral nervous system: implications for pain, cognition, and neurogenesis Radiology 2020 297 407 16 10.1148/radiol.2020192645 Open DOISearch in Google Scholar

9. Benzon HT, Maus TP, Kang HR, Provenzano DA, Bhatia A, Diehn F, et al. The use of contrast agents in interventional pain procedures: a multispecialty and multisociety practice advisory on nephrogenic systemic fibrosis, gadolinium deposition in the brain, encephalopathy after unintentional intrathecal gadolinium injection, and hypersensitivity reactions. Anesth Analg 2021; 133: 535–52. doi: 10.1213/ANE.0000000000005443 BenzonHT MausTP KangHR ProvenzanoDA BhatiaA DiehnF The use of contrast agents in interventional pain procedures: a multispecialty and multisociety practice advisory on nephrogenic systemic fibrosis, gadolinium deposition in the brain, encephalopathy after unintentional intrathecal gadolinium injection, and hypersensitivity reactions Anesth Analg 2021 133 535 52 10.1213/ANE.0000000000005443 Open DOISearch in Google Scholar

10. Ward KM, Aletras AH, Balaban RS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000; 143: 79–87. doi: 10.1006/jmre.1999.1956 WardKM AletrasAH BalabanRS A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST) J Magn Reson 2000 143 79 87 10.1006/jmre.1999.1956 Open DOISearch in Google Scholar

11. Zhou J, Payen JF, Wilson DA, Traystman RJ, van Zijl PC. Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI. Nat Med 2003; 9: 1085–90. doi: 10.1038/nm907 ZhouJ PayenJF WilsonDA TraystmanRJ van ZijlPC Using the amide proton signals of intracellular proteins and peptides to detect pH effects in MRI Nat Med 2003 9 1085 90 10.1038/nm907 Open DOISearch in Google Scholar

12. Chen Z, Han Z, Liu G. Repurposing clinical agents for chemical exchange saturation transfer magnetic resonance imaging: current status and future perspectives. Pharmaceuticals 2020; 14: 11. doi: 10.3390/ph14010011 ChenZ HanZ LiuG Repurposing clinical agents for chemical exchange saturation transfer magnetic resonance imaging: current status and future perspectives Pharmaceuticals 2020 14 11 10.3390/ph14010011 Open DOISearch in Google Scholar

13. Zhou J, Heo HY, Knutsson L, van Zijl PCM, Jiang S. APT-weighted MRI: Techniques, current neuro applications, and challenging issues. J Magn Reson Imaging 2019; 50: 347–64. doi: 10.1002/jmri.26645 ZhouJ HeoHY KnutssonL van ZijlPCM JiangS APT-weighted MRI: Techniques, current neuro applications, and challenging issues J Magn Reson Imaging 2019 50 347 64 10.1002/jmri.26645 Open DOISearch in Google Scholar

14. Meng N, Wang XJ, Sun J, Huang L, Wang Z, Wang KY. Comparative study of amide proton transfer-weighted imaging and intravoxel incoherent motion imaging in breast cancer diagnosis and evaluation. J Magn Reson Imaging 2020; 52: 1175–86. doi: 10.1002/jmri.27190 MengN WangXJ SunJ HuangL WangZ WangKY Comparative study of amide proton transfer-weighted imaging and intravoxel incoherent motion imaging in breast cancer diagnosis and evaluation J Magn Reson Imaging 2020 52 1175 86 10.1002/jmri.27190 Open DOISearch in Google Scholar

15. Zaric O, Farr A, Poblador Rodriguez E, Mlynarik V, Bogner W, Gruber S. 7T CEST MRI: A potential imaging tool for the assessment of tumor grade and cell proliferation in breast cancer. Magn Reson Imaging 2019; 59: 77–87. doi: 10.1016/j.mri.2019.03.004 ZaricO FarrA Poblador RodriguezE MlynarikV BognerW GruberS 7T CEST MRI: A potential imaging tool for the assessment of tumor grade and cell proliferation in breast cancer Magn Reson Imaging 2019 59 77 87 10.1016/j.mri.2019.03.004 Open DOISearch in Google Scholar

16. Meng N, Wang X, Sun J, Han D, Bai Y, Wei W. A comparative study of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in the diagnosis and evaluation of breast cancer. Eur Radiol 2021; 31: 1707–17. doi: 10.1007/s00330-020-07169-x MengN WangX SunJ HanD BaiY WeiW A comparative study of the value of amide proton transfer-weighted imaging and diffusion kurtosis imaging in the diagnosis and evaluation of breast cancer Eur Radiol 2021 31 1707 17 10.1007/s00330-020-07169-x Open DOISearch in Google Scholar

17. Dula AN, Arlinghaus LR, Dortch RD, Dewey BE, Whisenant JG, Ayers GD. Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response. Magn Reson Med 2013; 70: 216–24. doi: 10.1002/mrm.24450 DulaAN ArlinghausLR DortchRD DeweyBE WhisenantJG AyersGD Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response Magn Reson Med 2013 70 216 24 10.1002/mrm.24450 Open DOISearch in Google Scholar

18. Togao O, Yoshiura T, Keupp J, Hiwatashi A, Yamashita K, Kikuchi K, et al. Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. Neuro Oncol 2014; 16: 441–8. doi: 10.1093/neuonc/not158 TogaoO YoshiuraT KeuppJ HiwatashiA YamashitaK KikuchiK Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades Neuro Oncol 2014 16 441 8 10.1093/neuonc/not158 Open DOISearch in Google Scholar

19. Hammond ME. Commentary: improving breast cancer testing for patients-the secret sauce is collaboration. J Oncol Pract 2010; 6: 198. doi: 10.1200/JOP.777012 HammondME Commentary: improving breast cancer testing for patients-the secret sauce is collaboration J Oncol Pract 2010 6 198 10.1200/JOP.777012 Open DOISearch in Google Scholar

20. Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol 2013; 31: 3997–4013. doi: 10.5858/arpa.2013-0953-SA WolffAC HammondME HicksDG DowsettM McShaneLM AllisonKH Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update J Clin Oncol 2013 31 3997 4013 10.5858/arpa.2013-0953-SA Open DOISearch in Google Scholar

21. Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thürlimann B, et al. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 2013; 24: 2206–23. doi: 10.1093/annonc/mdt303 GoldhirschA WinerEP CoatesAS GelberRD Piccart-GebhartM ThürlimannB Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 Ann Oncol 2013 24 2206 23 10.1093/annonc/mdt303 Open DOISearch in Google Scholar

22. Guo Z, Qin X, Mu R, Lv J, Meng Z, Zheng W, et al. Amide proton transfer could provide more accurate lesion characterization in the transition zone of the prostate. J Magn Reson Imaging. 2022; 56: 1311–9. doi: 10.1002/jmri.28204 GuoZ QinX MuR LvJ MengZ ZhengW Amide proton transfer could provide more accurate lesion characterization in the transition zone of the prostate J Magn Reson Imaging 2022 56 1311 9 10.1002/jmri.28204 Open DOISearch in Google Scholar

23. Yang L, Wang L, Tan Y, Dan H, Xian P, Zhang Y, et al. Amide proton transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study. Cancer Imaging 2023; 23: 3. doi: 10.1186/s40644-022-00515-w YangL WangL TanY DanH XianP ZhangY Amide proton transfer-weighted MRI combined with serum prostate-specific antigen levels for differentiating malignant prostate lesions from benign prostate lesions: a retrospective cohort study Cancer Imaging 2023 23 3 10.1186/s40644-022-00515-w Open DOISearch in Google Scholar

24. Tian S, Chen A, Li Y, Wang N, Ma C, Lin L, et al. The combined application of amide proton transfer imaging and diffusion kurtosis imaging for differentiating stage Ia endometrial carcinoma and endometrial polyps. Magn Reson Imaging 2023; 99: 67–72. doi: 10.1016/j.mri.2022.12.026 TianS ChenA LiY WangN MaC LinL The combined application of amide proton transfer imaging and diffusion kurtosis imaging for differentiating stage Ia endometrial carcinoma and endometrial polyps Magn Reson Imaging 2023 99 67 72 10.1016/j.mri.2022.12.026 Open DOISearch in Google Scholar

25. Li Y, Lin CY, Qi YF, Wang XQ, Chen B, Zhou HL, et al. Non-invasive differentiation of endometrial adenocarcinoma from benign lesions in the uterus by utilization of amide proton transfer-weighted MRI. Mol Imaging Biol 2021; 23: 446–55. doi: 10.1007/s11307-020-01565-x LiY LinCY QiYF WangXQ ChenB ZhouHL Non-invasive differentiation of endometrial adenocarcinoma from benign lesions in the uterus by utilization of amide proton transfer-weighted MRI Mol Imaging Biol 2021 23 446 55 10.1007/s11307-020-01565-x Open DOISearch in Google Scholar

26. Loi L, Zimmermann F, Goerke S, Korzowski A, Meissner JE, Deike-Hofmann K, et al. Relaxation-compensated CEST (chemical exchange saturation transfer) imaging in breast cancer diagnostics at 7T. Eur J Radiol 2020; 129: 109068. doi: 10.1016/j.ejrad.2020.109068 LoiL ZimmermannF GoerkeS KorzowskiA MeissnerJE Deike-HofmannK Relaxation-compensated CEST (chemical exchange saturation transfer) imaging in breast cancer diagnostics at 7T Eur J Radiol 2020 129 109068 10.1016/j.ejrad.2020.109068 Open DOISearch in Google Scholar

27. Walker DT, Davenport MS, McGrath TA, McInnes MDF, Shankar T, Schieda N. Breakthrough hypersensitivity reactions to gadolinium-based contrast agents and strategies to decrease subsequent reaction rates: a systematic review and meta-analysis. Radiology 2020; 296: 312–21. doi: 10.1148/radiol.2020192855 WalkerDT DavenportMS McGrathTA McInnesMDF ShankarT SchiedaN Breakthrough hypersensitivity reactions to gadolinium-based contrast agents and strategies to decrease subsequent reaction rates: a systematic review and meta-analysis Radiology 2020 296 312 21 10.1148/radiol.2020192855 Open DOISearch in Google Scholar

28. Alabousi M, Davenport MS. Use of intravenous gadolinium-based contrast media in patients with kidney disease and the risk of nephrogenic systemic fibrosis: Radiology in training. Radiology 2021; 300: 279–84. doi: 10.1148/radiol.2021210044 AlabousiM DavenportMS Use of intravenous gadolinium-based contrast media in patients with kidney disease and the risk of nephrogenic systemic fibrosis: Radiology in training Radiology 2021 300 279 84 10.1148/radiol.2021210044 Open DOISearch in Google Scholar

29. Bhargava V, Singh K, Meena P, Sanyal R. Nephrogenic systemic fibrosis: a frivolous entity. World J Nephrol 2021; 10: 29–36. doi: 10.5527/wjn.v10.i3.29 BhargavaV SinghK MeenaP SanyalR Nephrogenic systemic fibrosis: a frivolous entity World J Nephrol 2021 10 29 36 10.5527/wjn.v10.i3.29 Open DOISearch in Google Scholar

30. Tweedle MF. Gadolinium retention in human brain, bone, and skin. Radiology 2021; 300: 570–1. doi: 10.1148/radiol.2021210957 TweedleMF Gadolinium retention in human brain, bone, and skin Radiology 2021 300 570 1 10.1148/radiol.2021210957 Open DOISearch in Google Scholar

31. Liu Z, Wen J, Wang M, Ren Y, Yang Q, Qian L, et al. Breast amide proton transfer imaging at 3 T: diagnostic performance and association with pathologic characteristics. J Magn Reson Imaging 2022; 57: 824–33. doi: 10.1002/jmri.28335 LiuZ WenJ WangM RenY YangQ QianL Breast amide proton transfer imaging at 3 T: diagnostic performance and association with pathologic characteristics J Magn Reson Imaging 2022 57 824 33 10.1002/jmri.28335 Open DOISearch in Google Scholar

32. Zhang N, Kang J, Wang H, Liu A, Miao Y, Ma X, et al. Differentiation of fibroadenomas versus malignant breast tumors utilizing three-dimensional amide proton transfer weighted magnetic resonance imaging. Clin Imaging 2022; 81: 15–23. doi: 10.1016/j.clinimag.2021.09.002 ZhangN KangJ WangH LiuA MiaoY MaX Differentiation of fibroadenomas versus malignant breast tumors utilizing three-dimensional amide proton transfer weighted magnetic resonance imaging Clin Imaging 2022 81 15 23 10.1016/j.clinimag.2021.09.002 Open DOISearch in Google Scholar

33. Lin Z, Zhang X, Guo L, Wang K, Jiang Y, Hu X, Huang Y, et al. Clinical feasibility study of 3D intracranial magnetic resonance angiography using compressed sensing. J Magn Reson Imaging 2019; 50: 1843–51. doi: 10.1002/jmri.26752 LinZ ZhangX GuoL WangK JiangY HuX HuangY Clinical feasibility study of 3D intracranial magnetic resonance angiography using compressed sensing J Magn Reson Imaging 2019 50 1843 51 10.1002/jmri.26752 Open DOISearch in Google Scholar

34. Zhang S, Keupp J, Wang X, Dimitrov I, Madhuranthakam AJ, Lenkinski RE, et al. Z-spectrum appearance and interpretation in the presence of fat: influence of acquisition parameters. Magn Reson Med 2018; 79: 2731–7. doi: 10.1002/mrm.26900 ZhangS KeuppJ WangX DimitrovI MadhuranthakamAJ LenkinskiRE Z-spectrum appearance and interpretation in the presence of fat: influence of acquisition parameters Magn Reson Med 2018 79 2731 7 10.1002/mrm.26900 Open DOISearch in Google Scholar

35. Strigel RM, Burnside ES, Elezaby M, Fowler AM, Kelcz F, Salkowski LR, et al. Utility of BI-RADS assessment category 4 subdivisions for screening breast MRI. AJR Am J Roentgenol 2017; 208: 1392–9. doi: 10.2214/AJR.16.16730 StrigelRM BurnsideES ElezabyM FowlerAM KelczF SalkowskiLR Utility of BI-RADS assessment category 4 subdivisions for screening breast MRI AJR Am J Roentgenol 2017 208 1392 9 10.2214/AJR.16.16730 Open DOISearch in Google Scholar